维普期刊资源整合服务平台（V6.5）

23篇 您的检索式：作者名="Killestein"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Oral treatment for multiple sclerosis显示文摘	Killestein J Rudick RA Polman CH	2011	Lancet Neurol2011，10，11：	1
2	Current trials in mutiple sclerosis:established evidence and future hopes显示文摘	Killestein J Polman CH		0，，3：	1
3	Higher levels of 25- hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women显示文摘	Kragt J van Amerongen B Killestein J	2009	Mult Scler2009，15，1：	1
4	Oral treatment for multiple sclerosis显示文摘	Joep Killestein Richard A Rudick Chris H Polman	2011	Lancet Neurology2011，，11：	1
5	Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients显示文摘	Vogt M Floris S Killestein J	2004	J Neuroimmunol2004，155，12：	1
6	Current trials in multiple sclerosis: established evidence and future hopes 显示文摘	Killestein J Polman CH	2005	Curr Opin Neurol2005，18，3：	1
7	Muhiple sclerosis following treatment with a cannabinoid receptor-1 antagonist 显示文摘	van Oosten BW Killestein J Mathus-Vliegen EM	2004	Muh Scler2004，10，3：	1
8	Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency显示文摘	Worthington V Killestein J Eikelenboom M J	2010	Neurology2010，75，18：	1
9	PML in a patient treated with dimethyl fumarate from a compounding pharmacy显示文摘	van Oosten BW Killestein J Barkhof F	2013	N Engl J Med2013，368，17：	1
10	Normal CSFferritin levels in MS suggest against etiologic role of chronic ve-nous insufficiency显示文摘	Worthington V Killestein J Eikelenboom MJ	2010	Neurology2010，75，18：	1
11	Normal CSF ferritin levels in MS suggest against etiologic role of chronic venous insufficiency显示文摘	Worthington V Killestein J Eikelenboom MJ	2010	Neurology2010，75，18：	1
12	Oral treatment for multiple sclerosis 显示文摘	Killestein J Rudick RA Polman CH	2011	Lancet Neurol2011，10，11：	1
13	Intracellular cytokine profile in T-cell subsets of multiple sclerosis patients: different features in primary progressive disease 显示文摘	Killestein J Drijver AF Graaff WL	2001	Muir Sclre2001，7，：	1
14	Oral treatment for multiple sclerosis显示文摘	Killestein J Rudick RA Polman CH	2011	Lancet Neurol2011，10，：	1
15	Statins for the treatment of multiple sclerosis:cautious hope显示文摘	Polman CH Killestein J	2004	Lancet2004，，：	1
16	Serum homocysteine levels in relation toclinical progression in multiple scler-osis显示文摘	Teunissen CE Killestein J Kmgt JJ	2008	J Neurol Neurosurg Psychiatry2008，79，12：	1
17	Serum homocysteine levels in relation to clinical progression in multiple sclerosis显示文摘	Teunissen CE Killestein J Kmgt JJ	2008	J Neurol Neurosurg Psychiatry2008，79，：	1
18	Quality of life during the finrst 6 months of interferon-beta treatment in patients with MS 显示文摘	Aronldus JH Killestein J Pfimings LE	2000	Mult Scter2000，6，5：	1
19	Nagelkerken L Osteopontinlevels and increased disease activity in relapsing remitting multiplesclerosis patients显示文摘	Vogt MH Floris S Killestein J	2004	Neuroimmunol2004，155，：	1
20	Quality of life duringthe first 6 months of interferon-beta treatment in patients with MS显示文摘	Arorddus JH Killestein J Pfimings LE	2009	Mult Scter2009，6，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示